CIBBIM - Nanomedicine
CIBBIM – Nanomedicine. Kidney Physiopathology
Anna Meseguer Navarro
Researchers Joan López Hellin, Gema Ariceta Iraola, Enric Trilla Herrera, Eduard Sarró Tauler, Luis Castro Sáder, David Lorente García, Alvaro Domingo Madrid Aris, Marina Muñoz López, Luis Enrique Lara Moctezuma, Ramón Vilalta Casas | Ph.D. Students Miguel Aranda Martin, Mónica Durán Fernández, Natalia Puig Gay, Jazmine Arévalo, Mónica Vall Palomar
Summary
The most relevant event in 2015 in our research group has been the consolidation of new research lines on pediatric kidney rare diseases. We have managed to align interests to develop projects of translational relevance that have been funded by competitive calls as well the patient associations Asdent and Hipofam, with which we work together. This is an example of cooperation between patients, clinicians and basic researchers, only possible in an institution like ours, of which we are really proud. Beyond these two projects on rare diseases, we have been granted three competitive projects to continue our research line, related to the study of androgens in kidney physiopathology, damage mechanisms and fibrosis prevention, renal cancer and segmental and focal glomerulosclerosis. The most translational part of these projects has been developed with the collaboration of urologists integrated to the group and with the nephrology service at our Hospital.